HK1223290A1 - 結合到人類白細胞抗原 類或 類分子上用作疫苗的腫瘤相關肽新製劑 - Google Patents

結合到人類白細胞抗原 類或 類分子上用作疫苗的腫瘤相關肽新製劑

Info

Publication number
HK1223290A1
HK1223290A1 HK16111596.7A HK16111596A HK1223290A1 HK 1223290 A1 HK1223290 A1 HK 1223290A1 HK 16111596 A HK16111596 A HK 16111596A HK 1223290 A1 HK1223290 A1 HK 1223290A1
Authority
HK
Hong Kong
Prior art keywords
hla
tumour
vaccine
molecules
class
Prior art date
Application number
HK16111596.7A
Other languages
English (en)
Chinese (zh)
Inventor
Lewandrowski Peter
Flohr Christian
Original Assignee
Immatics Biotechnologies Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP08008292A external-priority patent/EP2113253B1/en
Application filed by Immatics Biotechnologies Gmbh filed Critical Immatics Biotechnologies Gmbh
Publication of HK1223290A1 publication Critical patent/HK1223290A1/zh

Links

HK16111596.7A 2008-04-24 2016-10-05 結合到人類白細胞抗原 類或 類分子上用作疫苗的腫瘤相關肽新製劑 HK1223290A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4766908P 2008-04-24 2008-04-24
EP08008292A EP2113253B1 (en) 2008-04-30 2008-04-30 Novel formulations of tumour-associated peptides binding to human leukocyte antigen (HLA) class I or II molecules for vaccines

Publications (1)

Publication Number Publication Date
HK1223290A1 true HK1223290A1 (zh) 2017-07-28

Family

ID=47785995

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16111596.7A HK1223290A1 (zh) 2008-04-24 2016-10-05 結合到人類白細胞抗原 類或 類分子上用作疫苗的腫瘤相關肽新製劑

Country Status (3)

Country Link
JP (1) JP5921395B2 (ja)
CY (1) CY1112212T1 (ja)
HK (1) HK1223290A1 (ja)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997004801A1 (en) * 1995-07-27 1997-02-13 Genentech, Inc. Stabile isotonic lyophilized protein formulation
AU2004229458B2 (en) * 2003-04-11 2009-11-19 Antigenics, Inc. Improved heat shock protein-based vaccines and immunotherapies
TW200539855A (en) * 2004-03-15 2005-12-16 Wyeth Corp Calicheamicin conjugates
ES2330013T3 (es) * 2005-09-05 2009-12-03 Immatics Biotechnologies Gmbh Peptidos asociados a tumores unidos a moleculas del antigeno de leucocito humano (hla) de clase i o ii y vacunas contra el cancer relacionadas.
DK2113253T3 (da) * 2008-04-30 2010-07-19 Immatics Biotechnologies Gmbh Ny sammensætning af tumorassocierede peptider, der bindes til humant leukocyt-antigen (HLA) klasse I eller II molekyler, til vaccinebrug

Also Published As

Publication number Publication date
JP5921395B2 (ja) 2016-05-24
CY1112212T1 (el) 2015-12-09
JP2013028621A (ja) 2013-02-07

Similar Documents

Publication Publication Date Title
PL2111867T3 (pl) Nowe formulacje zawierające peptydy nowotworowe wiążące się z antygenami ludzkich leukocytów (HLA) klasy I i II do zastosowania w szczepionkach
DK2567707T3 (en) Composition of tumour-associated peptides and related anti-cancer vaccine
ZA201209640B (en) Anti-cemx antibodies capable of binding to human mige on b lymphocytes
PL2188313T3 (pl) Białka wiążące ludzki antygen c-fms
BRPI1008186A2 (pt) "aperfeiçoamentos do grampeador cirúrgico acionado"
SI2437753T1 (sl) Sintetični glukopiranozil-lipidni adjuvansi in cepivni sestavki, ki jih vsebujejo
ZA201204507B (en) Human antibodies to human angiopoietin-like protein 4
PL2575873T3 (pl) Zatężanie i liofilizacja antygenów szczepionkowych grypy
EP2629788A4 (en) USE OF HUMAN SERUM ALBUMIN TO REDUCE THE ANTIGENICITY OF THERAPEUTIC PROTEINS
ZA201201714B (en) Protein matrix vaccines of improved immunogenicity
EP2334701A4 (en) FULLY HUMAN ANTIBODIES AGAINST ANTIGENES ASSOCIATED WITH MELANOMA OF HIGH MOLECULAR WEIGHT AND USES THEREOF
PT2575872T (pt) Concentração de antigénios da vacina da gripe sem liofilização
IL205821A (en) Use of an immune formulation for the preparation of a pharmaceutical preparation for vaccination on the skin of mammals
HK1142813A1 (en) Survivin peptides as cancer vaccines
HK1215264A1 (zh) 類分子提呈的存活蛋白 的部分肽及其利用方法
EP2611926A4 (en) PREPARATION AND PURIFICATION OF A SUBUNIT VACCINE AGAINST GROUP B ISOLATES FROM NEISSERIA MENINGITIDIS (NM)
FR2932681B1 (fr) Peptides immunogenes issus de la proteine midkine comme vaccin anticancereux
IL212078A0 (en) Antibodies to modified human igf-1/e peptides
HK1223290A1 (zh) 結合到人類白細胞抗原 類或 類分子上用作疫苗的腫瘤相關肽新製劑
UA104572C2 (ru) Новые композиции опухолеассоциированных пептидов, которые связываются с молекулами i или ii класса лейкоцитарного антигена человека (hla) для разработки вакцин
EP2564867A4 (en) AUTOLOGOUS BIOLOGICAL VACCINE AGAINST CANCER